PERSPECTA

News from every angle

Back to headlines

NRx Pharmaceuticals Reports Q4 Earnings and Call Highlights

NRx Pharmaceuticals announced its Q4 GAAP EPS of -$1.34 and revenue of $1.23 million, with further details highlighted during its earnings call.

24 Mar, 16:37 — 24 Mar, 16:37
PostShare

Sources

Showing 1 of 2 sources

Coverage Timeline

First report: seeking-alpha · 24 Mar, 11:19Full coverage: 2 · 5hWindow: 5h
Left-leaningCenterRight-leaning